Non-homogeneous Markov processes for biomedical data analysis

Biometrical Journal

Volumn 47, Issue 3, 2005, Pages 369-376

  Ocaña Riola, Ricardo ^a  

^a ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

Author keywords

Cancer; Markov process; Stochastic processes

Indexed keywords

BIOINFORMATICS; DATA HANDLING; DISEASES; INFORMATION ANALYSIS; STOCHASTIC SYSTEMS;

ANALYSIS SOFTWARES; BIOMEDICAL DATA ANALYSIS; BIOMEDICAL SCIENCE; CANCER; CENSORED OBSERVATIONS; MARKOV MODELING; NON-HOMOGENEOUS; NON-HOMOGENEOUS MARKOV PROCESS; STANDARD SOFTWARE; TRANSITION TIME;

MARKOV PROCESSES;

EID: 22144489189     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/bimj.200310114     Document Type: Article

References (33)

1. Aalen, O. and Johansen, S. (1978). An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scandinavian Journal of Statistics 5, 141-150.
2. Aalen , O., Borgan, O., and Fekjcer, H. (2001). Covariate adjustment of event histories estimated from Markov chains: The additive approach. Biometrics 57, 108-116.
3. Andersen, P. K. (1988). Multistate models in survival analysis: A study of nephropathy and mortality in diabetes. Statistic in Medicine 7, 661-670.
4. Andersen, P. K., Borgan, O., Gill, R. D., and Keiding, N. (1992). Statistical models based on counting processes. Springer-Verlag, New York.
5. Billard, L. and Zhao, Z. (1994). Multiple-stage non-homogeneous Markov models for Acquired Immune Deficiency Syndrome epidemic. Journal of the Royal Statistical Society B 56, 673-686.
6. Chiang, C. L. (1980). An introduction to stochastic processes and their applications. John Wiley & Sons, New York.
7. Cleveland, W. S. (1993). Visualizing data. Hobart Press, New Jersey.
8. Collett, D. (2003). Modelling survival data in medical research (Second Edition). Chapman and Hall, Boca Raton.
9. De Gruttola, V. and Lagakos, S. W. (1989). Analysis of doubly-censored survival date, with application to AIDS. Biometrics 45, 1-11.
10. Feller, W. (1968). An introduction to probability theory and its applications. Vol I. John Wiley & Sons, New York.
11. Fleming, T. R. and Harrington, D. P. (1991). Counting Processes and Survival Analysis. John Wiley & Sons, New York.
12. Freedman, G. M. and Fowble, B. L. (2000). Local recurrence after mastectomy or breast-conserving surgery and radiation. Oncology 14, 1561-1581.
13. Frydman, H. (1992). A nonparametric estimation procedure for a periodically observed three-state Markov process with application to AIDS. Journal of the Royal Statistical Society B 54, 853-866.
14. Gentleman, R. C., Lawless, J. F., Lindsey, J. C., and Yan, P. (1994). Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease. Statistics in Medicine 13, 805-821.
15. Gerontidis, I. I. (1990). On certain aspects of non-homogeneous Markov systems in continuous time. Journal of Applied Probability 27, 530-544.
16. Janardan, K. G. (2002). On a distribution associated with a stochastic process in Ecology. Biometrical Journal, 44, 510-522.
17. Kalbfleisch, J. D. and Lawless, J. F. (1985). The analysis of panel data under a Markov assumption. Journal of the American Statistical Association 80, 863-871.
18. Kay, R. (1986). A Markov model for analysing cancer markers and disease states in survival studies. Biometrics 42, 855-865.
19. Islam, M. A. (1994). Multistate survival models for transitions and reverse transitions: an application to contraceptive use date. Journal of the Royal Statistical Society A 157, 441-455.
20. Longini, I. M., Clark, W. S., Byers, R. H., Ward, J. W., Darrow, W. W., Lemp, G. F., and Hethcote, H. W. (1989). Statistical analysis of the stages of HIV infection using a Markov model. Statistics in Medicine 8, 831-843.
21. Mariotto, A. B., Mariotti, S., Pezzotti, P., Rezza, G., and Verdecchia, A. (1992). Estimation of the Acquired Immunodeficiency Syndrome incubation period in intravenous drug users: A comparison with male homosexual. American Journal of Epidemiology 135, 428-437.
22. Mathsoft (1999). S-PLUS 2000. Mathsoft, Inc., Cambridge, MA.
23. McBain, C. A., Young, E. A., Swindell, R., Magee, B., and Stewart, A. L. (2003). Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcome. Clinical Oncological 15, 25-31.
24. Norberg, R. (2002). Basic life insurance Mathematics [Lecture Notes]. University of Copenhagen, Copenhagen.
25. Ocana-Riola, R. (2002). Two methods to estimate homogeneous Markov processes. Journal of Modern Applied Statistical Methods 1, 131-138.
26. Ohsumi, S., Sakamoto, G., Takashima, S., Koyama, H., Shin, E., Suemasu, K., et al. (2003). Long-term results of breast-conserving treatment for early-stage breast cancer in Japanese women from multicenter investigation. Japanese Journal of Clinical Oncological 33, 61-67.
27. Pendlebury, S. C., Ivanov, O., Renwick, S., and Stevens, G. N. (2003). Long-term review of a breast conservation series and patterns of care over 18 years. ANZ Journal of Surgery 73, 577-583.
28. Stranzl, H., Mayer, R., Quehenberger, F., Prettenhofer, U., Willfurth, P., Stoger, H., et al. (1999). Adjuvant radiotherapy in male breast cancer. Radiotherapy Oncology 53, 29-35.
29. Trajstman, A. C. (2002). A Markov chain model for Newcastle disease and its relevance to the intracerebral pathogenicity index. Biometrical Journal 44, 43-57.
30. Tsantas, N. and Vassiliou, P. C. G. (1993). The non-homogeneous Markov system in a stochastic environment. Journal of Applied Probability 30, 285-301.
31. Vujovic, O., Perera, F., Dar, A. R., Stit, L., Yu, E., Voruganti, S. M., et al. (1998). Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? International Journal of Radiation Oncology, Biology, Physics 40, 869-874.
32. Wang, P. and Puterman, M. L. (2001). Analysis of longitudinal data od epileptic seizure counts: A two state hidden Markov regression approach. Biometrical Journal 43, 941-962.
33. WHO (1980). WHO handbook for reporting results of cancer treatment (WHO offset publication No. 48). WHO, Geneve.